Hemodialysis techniques and advanced glycation end products

Contributions to Nephrology

Volumn 131, Issue , 2001, Pages 33-39

  Tessitore, Nicola ^a,c   Lapolla, Annunziata ^b   Nadia Arico C ^b   Gammaro, Linda ^a   Bernich, Patrizia ^a   Fedele, Domenico ^b  

^a Divisione Clinicizzata di Nefrologia   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Servizio Emodialisi Ospedale Policlinico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; DRUG DERIVATIVE; HEMODIALYSIS FLUID; LYSINE; PENTOSIDINE; PLASMA PROTEIN;

ARTIFICIAL MEMBRANE; BLOOD; CHEMISTRY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; HEMODIAFILTRATION; HEMOFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSTRUMENTATION; METHODOLOGY; MOLECULAR WEIGHT; RENAL REPLACEMENT THERAPY; REVIEW; ULTRAFILTRATION; UREMIA;

ARGININE; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; RENAL DIALYSIS; ULTRAFILTRATION; UREMIA;

EID: 0035526682     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (43)

1. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in ptients with diabetic nephropathy. N Engl J Med 1991; 325:836-842.
2. Odetti P, Fogarty J, Seil DR, Monnier VM: Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992;41:153-159.
3. Takahashi M, Kushida K, Kawana K, Ishihara C, Denda M, Inoue T, Horiuchi K: Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin Chem 1993;39: 2162-2165.
4. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Earth RH, Winston JA, Fuh H, Manogue KR, Cerami A, Vlassara H: Reactive glycosylation end products in diabetic uraemia and treatment of renal failure. Lancet 1994;343:1519-1522.
5. Papanastasiu P, Grass L, Rodela H, Patrikarea A, Oreopulos D, Diamandis EP: Immunological quantification of advanced glycosylation end products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994;46:216-222.
6. Dolhofer-Bliesener R, Lechner B, Deppisch R, Ritz E, Gerbitz KD: Immunological determination of advanced glycosylation end products in human blood and urine. Nephrol Dial Transplant 1995; 10:657-664.
7. Ateshkadi A, Johnson CA, Founds HW, Zimmerman SW: Serum advanced glycosylation end products in patients on hemodialysis and CAPD. Perit Dial Int 1995;15:129-133.
8. Takahashi M, Kushida K, Ishihara C, Denda M, Inoue T: Plasma pentosidine levels in uremic patients before and after hemodialysis. Scand J Urol Nephrol 1995;29:131-134.
9. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implication in the pathophysiology of pentosidine. J Am Soc Nephrol 1996;7:1198-1206.
10. Degenhardt TP, Grass L, Reddy S, Thorpe SR, Diamandis EP, Baynes JW: The serum concentration of the advanced glycation end product N-(carboxymethyl)lysine is increased in uremia. Kidney Int 1997;52:1064-1067.
11. Kumano K, Yokota S, Sakai T, Kobayashi N, Yoshida A, Yoshihara T, Shibata K, Izumi G, Wang H: Kinetic analysis of furosine and pentosidine in CAPD patients. Adv Perit Dial 1997;13:53-57.
12. Miyata T, Fu MX, Kurokawa K, van Ipersele de Strihou C, Thorpe SR, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia? Kidney Int 1998;54:1290-1295.
13. Motomiya Y, Oyama N, Iwamoto H, Uchimura T, Maruyama I: N-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis. Kidney Int 1998;54:1357-1366.
14. Izuhara Y, Miyata T, Ueda Y, Suzuki D, Asahi K, Inagi R, Sakai H, Kurokawa K: A sensitive and specific ELISA for plasma pentosidine. Nephrol Dial Transplant 1999;14:576-580.
15. Weiss MF: Pathogenic role of advanced glycation end products: An overview. Perit Dial Int 1999; 19(suppl 2):47-52.
16. Dawnay A, Millar DJ: The pathogenesis and consequences of AGE formation in uraemia and its treatment. Cell Mol Biol 1998;44:1081-1094.
17. Niwa T, Takeda N, Miyazaki T, Yoshizumi H, Tatematsu A, Maeda K, Ohara M, Tomiyama S, Niimura K: Elevated serum levels of 3-deoxyglucosone, a potent protein cross-linking intermediate of the Maillard reaction, in uremic patients. Nephron 1995;69:438-443.
18. Tsukushi S, Katsuzaki T, Aoyama I, Takayama F, Miyazaki T, Shimokata K, Niwa T: Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of the polyol pathway. Kidney Int 1999;55:1970-1976.
19. Bukala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H: Modification of low density lipoprotein by advanced glycation end products contributes to the dislipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994;91:9441-9445.
20. Makita Z, Yanagisawa K, Kuwajima S, Bucala R, Vlassara H, Koike T: The role of advanced glycosylation end products in the pathogenesis of atherosclerosis. Nephrol Dial Transplant 1996; 11(suppl 5):31-33.
21. Miyata T, Inagi R, Kurokawa K: Diagnosis, pathogenesis and treatment of dialysis-related amyloidosis. Miner Electrolyte Metab 1999;25:114-117.
22. Ritz E, Deppish R, Nawroth P: Toxicity of uraemia - Does it come of AGE? Nephrol Dial Transplant 1994;9:1-2.
23. Jadoul M, Ueda Y, Yasuda Y, Saito A, Robert A, Ishida N, Kurokawa K, van Ypersele de Strihou C, Miyata T: Influence of hemodialysis membrane type on pentosidine plasma level, a marker of 'carbonyl stress'. Kidney Int 1999;55:2487-2492.
24. Odetti P, Cosso L, Pronzato MA, Dapino D, Gurreri G: Plasma advanced glycosylation end products in maintenance hemodialysis patients. Nephrol Dial Transplant 1995;10:2110-2113.
25. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999;55:389-399.
26. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C: Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997;12:255-258.
27. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichi V, Wratten ML: An overview of hemodialysis and oxidant stress. Blood Purif 1999;17:118-126.
28. Friedlander MA, Wu Y, Schulak JA, Monnier VM, Hricik DE: Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995;25:445-451.
29. Miyata T, Ueda Y, Yoshida A, Sugiyama S, Iida Y, Jadoul M, Maeda K, Kurokawa K, van Ypersele de Strihou C: Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 1997;51:880-887.
30. Stein G, Franke S, Sperschneider H, Vienken J, Ueda Y, Miyata T, Kurokawa K: Decrease in serum pentosidine levels of ESRD patients during polysulfone haemodialysis. Nephrol Dial Transplant 1999;14:1606-1607.
31. Frank S, Sperschneider H, Vienken J, Mahiout A, Stein G: Decrease in serum-free pentosidine and AGE-peptide levels of ESRD patients during polysulfone dialysis (abstract). J Am Soc Nephrol 1999;10:261.
32. Friedlander MA, Wu YC, Elgawish A, Monnier VM: Early and advanced glycosylation end products. J Clin Invest 1996;97:728-735.
33. Odetti P, Robaudo C, Valentini S, Gurreri G, Faribaldi S, Angeletti S: Effect of a new vitamin E-coated membrane on glycoxidation during hemodialysis; in Ronco C, LaGreca G (eds): Vitamin E-Bonded Membrane. A Further Step in Dialysis Optimization. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 192-199.
34. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wasa T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 1998;9:2349-2356.
35. Stein G, Mahiout A, Schneider S, Matata BM, Borst S, Schaefer K: Elimination of beta-2-microglobulin, AGE beta-2-microglobulin and AGE-peptides from serum of ESRD patients during dialysis (abstract). J Am Soc Nephrol 1996;7:1420.
36. Fishbane S, Bucala R, Pereira BJG, Founds H, Vlassara H: Reduction of plasma apolipoprotein B by effective removal of circulating glycation derivatives in uremia. Kidney Int 1997;52:1645-1650.
37. Van Tellingen A, Schalkwijk CG, Teerlink T, Grooteman MPC, ter Wee PM, Nube MJ: AGE-peptides are cleared during hemodialysis with high permeable dialyzer (abstract). Am J Soc Nephrol 1999;10:283.
38. Fishbane S, Maesaka J, Mitsuhashi T, Adam G, Vlassara H: In vitro clearance of advanced glycosylation end products by conventional and high-flux hemodialysis membranes (abstract). J Am Soc Nephrol 1995;6:488.
39. Gerdemann A, Schinzel R, Munch G, Heidland H, Bahner U, Quellhorst E, Pohlmeier R, Vienken J: Removal of AGEs by hemodialysis, hemodialfiltration and hemofiltration (abstract). Abstract Book XXXVI Congress of ERA-EDTA, 1999, p 264.
40. Henle T, Deppisch R, Beck W, Hergesell O, Hansch GM, Ritz E: Advanced glycation end-products during hemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant 1999;14:1968-1975.
41. Sell DR, Monnier VM: Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in aging process. J Biol Chem 1989;264:21597-21602.
42. Buoncristiani U, Galli F, Benedetti S, Errico R, Beninati S, Ghibelli L, Floridi A, Canestrari F: Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes; in Ronco C (ed): Polymethylmethacrylate. A flexible membrane for a tailored dialysis. Contrib Nephrol. Basel, Karger, 1998, vol 125, pp 133-158.
43. Satoh M, Yamasaki Y, Odawara M, Kasahara J, Orimi S, Hashimoto M, Makino H: Anti-oxidative effects of vitamin E-modified dialysis filters on diabetic and non-diabetic hemodialysis patients (abstract). Abstract Book XVth International Congress of Nephrology, 1999, p 124.